Researchers find timing, dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence

by Bendta Schroeder,Massachusetts Institute of TechnologyNormal cells (blue) entering senescence (green to yellow) or apoptosis (purple to red) after treatment with chemotherapy. Credit: Bendta

Updated on: February 18,2024 17

Researchers find timing, dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence

by Bendta Schroeder,Massachusetts Institute of TechnologyNormal cells (blue) entering senescence (green to yellow) or apoptosis (purple to red) after treatment with chemotherapy. Credit: Bendta

Updated on:February 18,2024 17

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on: February 18,2024 19

Triple-drug therapy for post-transplant management of multiple myeloma

by University of Chicago Medical CenterCredit: Unsplash/CC0 Public DomainResearchers from the University of Chicago Medicine Comprehensive Cancer Center and colleagues in Poland report promising

Updated on:February 18,2024 19

Researchers use AI to understand lung cancer cell vulnerabilities

by University of MontanaMark Grimes, a researcher and University of Montana biology professor, uses AI to learn more about lung cancer vulnerabilities. Credit: University of Montana photo by Tomm

Updated on: February 18,2024 20

Researchers use AI to understand lung cancer cell vulnerabilities

by University of MontanaMark Grimes, a researcher and University of Montana biology professor, uses AI to learn more about lung cancer vulnerabilities. Credit: University of Montana photo by Tomm

Updated on:February 18,2024 20

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on: February 18,2024 15

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on:February 18,2024 15

Study could help explain why certain brain tumors don't respond well to immunotherapy

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread

Updated on: February 18,2024 15

Study could help explain why certain brain tumors don't respond well to immunotherapy

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread

Updated on:February 18,2024 15

Drug combination discovery may extend life expectancy of children with brain cancer

by Newcastle UniversityCredit: Unsplash/CC0 Public DomainNewcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain ca

Updated on: February 18,2024 18

Drug combination discovery may extend life expectancy of children with brain cancer

by Newcastle UniversityCredit: Unsplash/CC0 Public DomainNewcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain ca

Updated on:February 18,2024 18

Killing pancreatic cancer with T cells that supercharge themselves

by University of California, San FranciscoTherapeutic T cells engineered with tumor-triggered IL-2 production infiltrate and clear immune-excluded tumors. (A) We hypothesized that cell autonomous

Updated on: February 18,2024 20

Killing pancreatic cancer with T cells that supercharge themselves

by University of California, San FranciscoTherapeutic T cells engineered with tumor-triggered IL-2 production infiltrate and clear immune-excluded tumors. (A) We hypothesized that cell autonomous

Updated on:February 18,2024 20

Researchers use machine learning to unlock the genomic code in clinical cancer samples

by University of HelsinkiMutational signatures of formalin exposure. a C>T FFPE-only mutation count increases with formalin fixation time. We observed this increase in both unrepaired and repa

Updated on: February 18,2024 20

Researchers use machine learning to unlock the genomic code in clinical cancer samples

by University of HelsinkiMutational signatures of formalin exposure. a C>T FFPE-only mutation count increases with formalin fixation time. We observed this increase in both unrepaired and repa

Updated on:February 18,2024 20

Researcher looks at molecular changes for clues to disparities in breast cancer outcomes

by Medical University of South CarolinaPeggi Angel, Ph.D., is in looking at how socioeconomic stressors may influence metabolic processes that could in turn create a "tumor permissive"

Updated on: February 18,2024 19

Researcher looks at molecular changes for clues to disparities in breast cancer outcomes

by Medical University of South CarolinaPeggi Angel, Ph.D., is in looking at how socioeconomic stressors may influence metabolic processes that could in turn create a "tumor permissive"

Updated on:February 18,2024 19

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on: February 18,2024 17

New drug could be advance against glioma brain tumors

by Dennis ThompsonAn experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progress

Updated on:February 18,2024 17

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on: February 18,2024 14

Study: More paid sick leave results in more cancer screenings

by Tulane UniversityCredit: Unsplash/CC0 Public DomainFor most Americans, the two major obstacles to proper medical care are time and money. And while insurance can sometimes reduce health care c

Updated on:February 18,2024 14

Finances need to be a bigger part of our conversation about cancer, researchers say

by Maddie Massy-Westropp,University of New South WalesCredit: Unsplash/CC0 Public DomainWhen Jessie Oldfield was experiencing some bleeding at 23 weeks pregnant, she was worried that she had pre

Updated on: February 18,2024 17

Finances need to be a bigger part of our conversation about cancer, researchers say

by Maddie Massy-Westropp,University of New South WalesCredit: Unsplash/CC0 Public DomainWhen Jessie Oldfield was experiencing some bleeding at 23 weeks pregnant, she was worried that she had pre

Updated on:February 18,2024 17